EBITDA: Income before interest, taxes, depreciation and amortization.
MARKER THERAPEUTICS, INC. (MRKR) had EBITDA of $-4.26M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$0.86M |
|
$-4.02M |
|
-- |
|
$0.86M |
|
$5.12M |
|
$-4.26M |
|
$0.25M |
|
$-4.02M |
|
$-4.02M |
|
$-4.02M |
|
$-4.02M |
|
$-4.02M |
|
$-4.02M |
|
$-4.26M |
|
|
EBITDA |
$-4.26M |
13.96M |
|
13.96M |
|
$-0.29 |
|
$-0.29 |
|
| Balance Sheet Financials | |
$14.77M |
|
-- |
|
-- |
|
$14.77M |
|
$4.28M |
|
-- |
|
-- |
|
$4.28M |
|
$10.49M |
|
$10.49M |
|
$10.49M |
|
11.30M |
|
| Cash Flow Statement Financials | |
$-7.38M |
|
-- |
|
$0.00M |
|
$19.19M |
|
$11.81M |
|
$-7.38M |
|
$0.39M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.45 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-494.79% |
|
-494.79% |
|
-- |
|
-466.28% |
|
-466.28% |
|
$-7.38M |
|
-- |
|
-- |
|
-- |
|
0.06 |
|
-- |
|
0.51 |
|
174.98 |
|
-38.28% |
|
-38.28% |
|
-27.19% |
|
-38.28% |
|
$0.93 |
|
$-0.53 |
|
$-0.53 |
|